Home/ Supplements/ Omega 3/ Fish Oil Multi

Fish Oil Multi

product on market Softgel Capsule Carlson Safety: 99/100
99/100

This product looks safe

  • Folate: 340mg is 340.0× the Tolerable Upper Intake Level (1.0mg)
  • 62% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product contains basic macronutrients and Vitamin A, which is essential for maintaining normal vision and immune function. Research provides strong evidence for the role of Vitamin A in cellular health. However, the overall evidence coverage for this specific ingredient profile is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 340mg is 340.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Fish Oil Multi
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
60
Servings
Other Combinations
Product Type
62%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Total Fat
1 Gram(s) (1% DV)
Total Carbohydrates
1 Gram(s) (1% DV)
Protein
1 Gram(s)
Vitamin A
1500 mcg RAE (167% DV)
Vitamin C
300 mg (333% DV)
20 mcg (100% DV)
1.3× RDA — within safe limits 608 studies (A:16, B:251)
134 mg (893% DV)
8.9× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
7.5 mg (625% DV)
6.2× RDA — above typical dose 76 studies (A:0, B:33)
8.5 mg (654% DV)
6.5× RDA — above typical dose 13 studies (A:0, B:1)
20 mg (125% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
10 mg (588% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
340 mcg DFE (85% DV)
Exceeds UL by 340.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
60 mcg (2500% DV)
25.0× RDA — above typical dose 139 studies (A:1, B:44)
150 mcg (500% DV)
5.0× RDA — above typical dose 27 studies (A:0, B:11)
20 mg (400% DV)
4.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
35 mg (3% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
50 mg (12% DV)
Within RDA (0.1× RDA) 316 studies (A:8, B:159)
7.5 mg (68% DV)
Within RDA (0.7× RDA) 263 studies (A:6, B:134)
105 mcg (191% DV)
1.9× RDA — within safe limits 173 studies (A:0, B:67)
1 mg (111% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
1.5 mg (65% DV)
Within RDA (0.7× RDA) 9 studies — no high-quality reviews
120 mcg (343% DV)
3.4× RDA — above typical dose 199 studies (A:1, B:55)
37.5 mcg (83% DV)
Within RDA (0.8× RDA) 3 studies — no high-quality reviews
400 mcg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
1 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
200 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Soft Gel Shell Beeswax Soy Lecithin Rice Flour Soybean Oil Microcrystalline Cellulose Olive Oil Medium Chain Triglyceride Oil
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults: take one soft gel daily at mealtime with a full glass of water.

Warnings & Precautions

Contains soy and fish (anchovy, sardine and mackerel).

Formulation Notes

Omega-3s with Vitamins & Minerals

Heart health Brain function Optimal wellness

A super-strength, iron-free, balanced formula.

Gluten-free No artificial preservatives

An FDA Regulated Facility

Additional Information

Freshness & potency Purity guaranteed

Metadata

Product Details

UPC / SKU0 88395 01580 9
DSLD Entry Date2021-01-22
Product TypeOther Combinations
FormSoftgel Capsule
BrandCarlson
DSLD ID242168
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.